// App-Quantinova.ai

2055 : A first-in-class hemoglobin-floxuridine conjugate for the treatment of advanced stage liver cancer

Researchers

Presenter

  • Steve Brookes

Principal Investigators

  • Murray J. Cutler

  • Jin Seog Seo

  • Gord Adamson

  • David Bell

Medical Centers

  • Therapure Biopharma Inc., Mississauga, ON, Canada

Locations

  • Canada

Companies

  • Therapure BioPharma,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • floxuridine

  • TBI 302

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • First-In-Human

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved